Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol

NCT00943579 is registered in ClinicalTrials.gov with The Children's Health Council as lead sponsor.

NCT NCT00943579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00943579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol
Lead sponsor
The Children's Health Council
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2009
Completion date
March 31, 2012
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autistic disorder